TNYA
Tenaya Therapeutics Inc
NASDAQ: TNYA · HEALTHCARE · BIOTECHNOLOGY
$0.69
+4.66% today
Updated 2026-04-30
Market cap
$145.87M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.59
Dividend yield
—
52W range
$0 – $2
Volume
4.3M
Tenaya Therapeutics Inc (TNYA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-83.80%
ROA
-43.70%
Debt/equity
0.14x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-25.78M | — | — | — |
| 2020 | $0.00 | $-38.40M | — | — | — |
| 2021 | $0.00 | $-69.65M | — | — | — |
| 2022 | $0.00 | $-123.66M | — | — | — |
| 2023 | $0.00 | $-124.08M | — | — | — |
| 2024 | $0.00 | $-111.13M | — | — | — |
| 2025 | $0.00 | $-90.60M | — | — | — |